Description
Caboxen 20 mg contains the active ingredient cabozantinib, a targeted tyrosine kinase inhibitor (TKI). It is primarily used to treat advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and medullary thyroid cancer. The medication works by blocking specific proteins (such as VEGFR, MET, and AXL) that contribute to the growth, spread, and survival of cancer cells. [1, 2, 3]
Key Administration Rules
- How it is taken: It is an oral medication taken as directed by a healthcare professional. [1]

Reviews
There are no reviews yet.